Answers are grounded in this paper and cite their sources.
The occurrence of concomitant polymorphism in 3-fluoro- N -(3-fluorophenyl) benzamide has been identified to be due to the disorder in the crystal structure. Of the two modifications, the plate form (Form I) crystallizes in the monoclinic centrosymmetric space group C 2/ c with Z = 4, and the needle form (Form II) crystallizes in the noncentrosymmetric space group P 2 1 with Z = 2. An interesting positional disorder at the bridging atoms in both forms holds the molecular conformation identical, while subtle variations brought by N−H···O hydrogen bonds along with weak C−H···F and F···F interactions result in packing polymorphism.
No takes yet. Share an insight, caveat, or question.
Chopra et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: